Smoltek Nanotech Holding AB (publ) resolves on the record date for allotment of warrants of series TO 8
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.
Smoltek Nanotech Holding AB (publ) ("Smoltek" or the "Company") announces that the record date for allotment of warrants of series TO 8 has been set to December 18, 2023. The exercise period to subscribe for new shares with the support of warrants of series TO 8 will be from and including September 4, 2024, to and including September 18, 2024.
As announced by press release on December 7, 2023, the board of Smoltek has decided to distribute warrants of series TO 8 free of charge to shareholders in the Company. The record date to receive warrants of series TO 8 has been set to December 18, 2023. Therefore, the last day of trading in the Company’s share including the right to receive warrants is December 14, 2023, and the first day of trading in the Company’s share excluding the right to receive warrants is December 15, 2023.
The Company’s existing shareholders will receive one (1) free warrant of series TO 8 for every nine (9) shares held in the Company on the record date.
Terms and information regarding warrants of series TO 8
Each warrant of series TO 8 gives the right to subscribe for one (1) new share in the Company during the period from and including September 4, 2024, to and including September 18, 2024. The subscription price for shares supported by warrants of series TO 8 amounts to SEK 3.60 per share.
The board of the Company decided on December 7, 2023, to issue 1,666,666 warrants of series TO 8 to investors in two directed issues, of which 72,125 warrants are conditional on approval by general meeting. On the same day, the board decided to issue 1,802,466 warrants of series TO 8 to the Company to be allotted to the shareholders of the Company as described above. Thus, a maximum of 3,469,132 warrants of series TO 8 will be issued. If all the Company's 3,469,132 issued warrants of series TO 8 are exercised, the Company receive a maximum of approximately SEK 12.5 million before transaction costs.
Advisers
Mangold Fondkommission AB is the financial advisor and MAQS Advokatbyrå AB is the legal advisor to the Company in connection with the transaction.
About Smoltek
Smoltek is a Swedish technology company based in Gothenburg, specialized in the development and integration of carbon nanotechnology. The technology is used in the manufacture of vertical carbon nanostructures to create a three-dimensional surface in precision-defined patterns to solve advanced materials engineering problems in the process and semiconductor industry. Today, we focus on capturing the potential of the digital mobile phone revolution and the development of green energy production, which has resulted in the Company's two different business areas: semiconductors and hydrogen. In the semiconductor business area, the Company obtains ultra-thin capacitors intended for decoupling capacitors for application processes in mobile phones, and in the hydrogen business area, the first product is planned to be a highly efficient cell material intended for use in PEM electrolyzers to drastically reduce investment cost to produce fossil-free hydrogen. Smoltek’s technology makes components and materials thinner, more energy efficient, more powerful, and cheaper. This is made possible by the three-dimensional surface structure of the carbon nanostructures, which creates a surface that can be refined multiple times in the same volume for, for example, electrical and chemical processes. Smoltek has a strongly patent-protected technology consisting of roughly 110 patent assets within 20 patent families, of which 83 are currently granted patents. The company's stock is listed on the Spotlight Stock Market. For more information, go to www.smoltek.com/investors.
Important information
Publication, release, or distribution of this press release may in certain jurisdictions be subject to legal restrictions and persons in the jurisdictions where this press release has been made public or distributed should inform themselves of and follow such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer, or a solicitation of an offer, to acquire or subscribe for any securities in Smoltek in any jurisdiction, neither from Minesto nor from anyone else.
This press release does not identify, or purport to identify, risks (direct or indirect) that may be associated with an investment in the Company. The information contained in this announcement is for the sole purpose of describing the allocation of warrants of series TO 8 and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness.
This press release does not constitute an offer or invitation to acquire or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration or an applicable exemption from registration under the U.S. Securities Act of 1933 ("Securities Act") and may not be offered or sold in the United States without being registered, exempt from registration, or in a transaction not subject to the registration requirements of the Securities Act. There is no intention to register any securities mentioned herein in the United States or to make a public offering of such securities in the United States. The information in this press release may not be published, disclosed, copied, reproduced, or distributed, directly or indirectly, in whole or in part, in or to the United Kingdom, the United States, Canada, Japan, Australia, Belarus, Hong Kong, New Zealand, Russia, Switzerland, Singapore, South Africa, South Korea, or any other jurisdiction where such publication, disclosure, or distribution of this information would violate applicable laws and regulations.
Within the European Economic Area, no offer is made to the public of securities in any country other than Sweden. In other member states of the European Union, such an offer can only be made in accordance with an exception in the Prospectus Regulation (EU) 2017/1129.
Forward-Looking Statements
This press release contains forward-looking statements regarding the Company's intentions, assessments, or expectations concerning the Company's future results, financial position, liquidity, development, prospects, expected growth, strategies, and opportunities, as well as the markets in which the Company operates. Forward-looking statements are statements that do not relate to historical facts and can be identified by expressions such as "believes," "expects," "anticipates," "intends," "estimates," "will," "may," "assumes," "should," "could," and, in each case, negations thereof, or similar expressions that imply indications or predictions regarding future developments or trends and are not based on historical facts. The forward-looking statements in this press release are based on various assumptions, many of which are based on additional assumptions. While the Company believes that the assumptions reflected in these forward-looking statements are reasonable, there can be no assurance that they will materialize or prove to be correct. Since these assumptions are based on assumptions or estimates and are subject to risks and uncertainties, the actual results or outcomes, for various reasons, may differ materially from what is indicated by the forward-looking statements. Such risks, uncertainties, contingencies, and other significant factors may cause the actual events to differ materially from the expectations expressly or impliedly stated in this press release through the forward-looking statements. The Company does not guarantee that the assumptions underlying the forward-looking statements in this press release are correct, and each reader of the press release should not unduly rely on the forward-looking statements in this press release. The information, opinions, and forward-looking statements expressly or impliedly stated herein are provided only as of the date of this press release and may change. Neither the Company nor any other party undertakes to review, update, confirm, or publicly announce any revision to any forward-looking statement to reflect events occurring or circumstances arising with respect to the content of this press release, unless required by law or the Spotlight Stock Market's regulations for issuers
For further information
Håkan Persson, CEO of Smoltek Nanotech Holding AB
E-mail: hakan.persson@smoltek.com
Phone: +46 317 01 03 05
Website: www.smoltek.com/investors
Smoltek develops process technology and concepts to solve advanced materials engineering problems in several industrial sectors. The company protects its unique carbon nanotechnology through an extensive patent portfolio, consisting of more than 110 applied for patents, of which 83 have been granted. Smoltek's share is listed on Spotlight Stock Market under the short name SMOL. Smoltek is a development company and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.